Aptorum Group Ltd.
(NASDAQ : APM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. 2.31%34.520.9%$1201.27m
JNJJohnson & Johnson 0.46%141.030.7%$1103.14m
BMYBristol-Myers Squibb Co. 0.29%59.151.0%$968.91m
MRKMerck & Co., Inc. 0.87%78.800.7%$857.43m
ABBVAbbVie, Inc. -0.25%98.891.9%$812.92m
LLYEli Lilly & Co. 0.33%163.831.1%$690.12m
AZNAstraZeneca Plc 0.92%53.811.2%$300.81m
RPRXRoyalty Pharma Plc -1.59%45.730.1%$252.67m
VXRTVaxart, Inc. -7.88%7.370.0%$216.05m
NVSNovartis AG -0.32%87.570.2%$159.75m
GSKGlaxoSmithKline Plc 0.87%41.220.2%$121.90m
RGENRepligen Corp. 1.98%126.657.1%$118.03m
NVONovo Nordisk A/S 1.05%66.370.1%$93.27m
RETAReata Pharmaceuticals, Inc. 2.56%157.853.4%$86.77m
SNYSanofi 0.68%51.620.2%$80.25m

Company Profile

Aptorum Group Ltd. is a pharmaceutical company, which engages in the development and commercialization of therapeutic and diagnostic technologies. It operates through the following segments: Therapeutics and Non-Therapeutics. The Therapeutics segment seeks to develop various drug molecules and certain technologies for the treatment and diagnosis of human disease conditions in neurology, infectious diseases, gastroenterology, oncology, and other disease areas. The Non-Therapeutics segment encompasses the development of surgical robotics and medical devices; and the activities of AML Clinic. The company was founded by Ian Huen on September 13, 2010 and is headquartered in Hong Kong.